158 related articles for article (PubMed ID: 8077384)
1. Detection of cytomegalovirus DNA in sera of liver transplant recipients.
Patel R; Smith TF; Espy M; Wiesner RH; Krom RA; Portela D; Paya CV
J Clin Microbiol; 1994 Jun; 32(6):1431-4. PubMed ID: 8077384
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of PCR primers for early diagnosis of cytomegalovirus infection following liver transplantation.
Mendez JC; Espy MJ; Smith TF; Wilson JA; Paya CV
J Clin Microbiol; 1998 Feb; 36(2):526-30. PubMed ID: 9466770
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients.
Wirgart BZ; Claesson K; Eriksson BM; Brundin M; Tufveson G; Tötterman T; Grillner L
Clin Diagn Virol; 1996 Nov; 7(2):99-110. PubMed ID: 9137866
[TBL] [Abstract][Full Text] [Related]
4. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.
Solano C; Muñoz I; Gutiérrez A; Farga A; Prósper F; García-Conde J; Navarro D; Gimeno C
J Clin Microbiol; 2001 Nov; 39(11):3938-41. PubMed ID: 11682510
[TBL] [Abstract][Full Text] [Related]
5. Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipients.
Aspin MM; Gallez-Hawkins GM; Giugni TD; Tegtmeier B; Lang DJ; Schmidt GM; Forman SJ; Zaia JA
J Clin Microbiol; 1994 Sep; 32(9):2266-9. PubMed ID: 7814556
[TBL] [Abstract][Full Text] [Related]
6. Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy.
Brennan DC; Garlock KA; Lippmann BA; Buller RS; Gaudreault-Keener M; Lowell JA; Miller SB; Shenoy S; Howard TK; Storch GA
J Am Soc Nephrol; 1997 Jan; 8(1):118-25. PubMed ID: 9013456
[TBL] [Abstract][Full Text] [Related]
7. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
[TBL] [Abstract][Full Text] [Related]
8. Three-year experience with human cytomegalovirus infections in heart transplant recipients.
Grossi P; Revello MG; Minoli L; Percivalle E; Zavattoni M; Poma G; Martinelli L; Gerna G
J Heart Transplant; 1990; 9(6):712-9. PubMed ID: 2177498
[TBL] [Abstract][Full Text] [Related]
9. Monitoring levels of human cytomegalovirus DNA in blood after liver transplantation.
Drouet E; Colimon R; Michelson S; Fourcade N; Niveleau A; Ducerf C; Boibieux A; Chevallier M; Denoyel G
J Clin Microbiol; 1995 Feb; 33(2):389-94. PubMed ID: 7714198
[TBL] [Abstract][Full Text] [Related]
10. Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
Jain A; Orloff M; Kashyap R; Lansing K; Betts R; Mohanka R; Menegus M; Ryan C; Bozorgzadeh A
Transplant Proc; 2005 Sep; 37(7):3182-6. PubMed ID: 16213344
[TBL] [Abstract][Full Text] [Related]
11. Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients.
Toyoda M; Carlos JB; Galera OA; Galfayan K; Zhang X; Sun Z; Czer LS; Jordan SC
Transplantation; 1997 Apr; 63(7):957-63. PubMed ID: 9112347
[TBL] [Abstract][Full Text] [Related]
12. Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients.
Delgado R; Lumbreras C; Alba C; Pedraza MA; Otero JR; Gómez R; Moreno E; Noriega AR; Payá CV
J Clin Microbiol; 1992 Jul; 30(7):1876-8. PubMed ID: 1321171
[TBL] [Abstract][Full Text] [Related]
13. Qualitative and semiquantitative polymerase chain reaction testing for cytomegalovirus DNA in serum allows prediction of CMV related disease in liver transplant recipients.
Evans PC; Soin A; Wreghitt TG; Alexander GJ
J Clin Pathol; 1998 Dec; 51(12):914-21. PubMed ID: 10070333
[TBL] [Abstract][Full Text] [Related]
14. A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients.
Patel R; Smith TF; Espy M; Portela D; Wiesner RH; Krom RA; Paya CV
J Infect Dis; 1995 Apr; 171(4):1010-4. PubMed ID: 7706778
[TBL] [Abstract][Full Text] [Related]
15. Preemptive strategy for ganciclovir administration against cytomegalovirus in liver transplantation recipients.
Daly JS; Kopasz A; Anandakrishnan R; Robins T; Mehta S; Halvorsen M; Katz E
Am J Transplant; 2002 Nov; 2(10):955-8. PubMed ID: 12482148
[TBL] [Abstract][Full Text] [Related]
16. Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients.
Gerna G; Baldanti F; Lilleri D; Parea M; Alessandrino E; Pagani A; Locatelli F; Middeldorp J; Revello MG
J Clin Microbiol; 2000 May; 38(5):1845-53. PubMed ID: 10790111
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and monitoring of acute cytomegalovirus infection in peripheral blood of transplant recipients by nested reverse transcriptase polymerase chain reaction (RT-PCR).
Lassner D; Geissler F; Bosse S; Hofmann J; Witzigmann H; Remke H; Hauss J; Wagner O
Transpl Int; 2000; 13 Suppl 1():S366-71. PubMed ID: 11112034
[TBL] [Abstract][Full Text] [Related]
18. Preemptive treatment approach to cytomegalovirus (CMV) infection in solid organ transplant patients: relationship between compliance with the guidelines and prevention of CMV morbidity.
Künzle N; Petignat C; Francioli P; Vogel G; Seydoux C; Corpataux JM; Sahli R; Meylan PR
Transpl Infect Dis; 2000 Sep; 2(3):118-26. PubMed ID: 11429022
[TBL] [Abstract][Full Text] [Related]
19. Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.
Boeckh M; Huang M; Ferrenberg J; Stevens-Ayers T; Stensland L; Nichols WG; Corey L
J Clin Microbiol; 2004 Mar; 42(3):1142-8. PubMed ID: 15004066
[TBL] [Abstract][Full Text] [Related]
20. Prevention of recurrent cytomegalovirus disease in renal and liver transplant recipients: effect of oral ganciclovir.
Turgeon N; Fishman JA; Doran M; Basgoz N; Tolkoff-Rubin NE; Cosimi AB; Rubin RH
Transpl Infect Dis; 2000 Mar; 2(1):2-10. PubMed ID: 11429003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
